CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

Glioblastoma (GB) is the most common and aggressive primary brain tumor in adults and currently incurable. Despite multimodal treatment regimens, median survival in unselected patient cohorts is <1 year, and recurrence remains almost inevitable. Escape from immune surveillance is thought to contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Michael C., Zhang, Congcong, Harter, Patrick N., Romanski, Annette, Strassheimer, Florian, Senft, Christian, Tonn, Torsten, Steinbach, Joachim P., Wels, Winfried S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868035/
https://www.ncbi.nlm.nih.gov/pubmed/31798595
http://dx.doi.org/10.3389/fimmu.2019.02683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868035/
https://www.ncbi.nlm.nih.gov/pubmed/31798595
http://dx.doi.org/10.3389/fimmu.2019.02683

Ejemplares similares